Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.
Searching…
See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.
See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Jun 26, 2024 · Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.
Up to 30% of patients taking antipsychotics may develop tardive dyskinesia (TD). Recent evidence-based recommendations demonstrate an unmet need for effective TD management. This systematic review was designed to upda...
Jun 17, 2025 · Learn about Austedo (deutetrabenazine) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
Recognition and Management of Antipsychotic-induced Movement Disorders Antipsychotic-induced movement disorders commonly seen in clinical practice include parkinsonism, akathisia, tardive dyskinesia and acute dystonia...
Feb 6, 2026 · Antipsychotic-induced-movement-disorders-can-mimic-tardive-dyskinesia-mdash-learn-key-differences-symptoms-and-diagnostic-clues-for-accurate-treatment
May 14, 2025 · US Pharm. 2025;50 (5):HS2-HS5. ABSTRACT: Tardive dyskinesia (TD) is a potentially permanent neurologic disorder that is primarily associated with dopamine receptor antagonists, most commonly antipsychot...